You have 9 free searches left this month | for more free features.

City

Condition

Advanced Breast Cancer (1)

Breast Cancer (1)

HER2-negative Breast Cancer (1)

Hormone Receptor Positive Tumor (1)

Metastatic Breast Cancer (1)

PIK3CA Mutation (1)

Solid Tumor, Adult (1)

Unresectable Solid Tumor (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Relay Therapeutics, Inc. (1)

Collaborator

Intervention

abemaciclib (1)

fulvestrant (1)

palbociclib (1)

ribociclib (1)

rly-5836 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

rly-5836

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

Not yet recruiting

PIK3CA Mutation
+7 more

RLY-5836
+4 more

(no location specified)

Mar 7, 2023